Similar articles for PMID: 17195205

Year	Number of Results
1994	1
1996	5
1998	9
2000	3
2001	7
2002	33
2003	33
2004	80
2005	69
2006	74
2007	49
2008	26
2009	15
2010	17
2011	11
2012	19
2013	14
2014	6
2015	10
2016	8
2017	4
2018	6
2019	6
2020	5
2021	3
2022	1
2024	0

1

Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.

Ge J, Qian J, Wang X, Wang Q, Yan W, Yan Y, Fan B, Ge L, Liu X. Ge J, et al. Catheter Cardiovasc Interv. 2007 Feb 1;69(2):198-202. doi: 10.1002/ccd.20926. Catheter Cardiovasc Interv. 2007. PMID: 17195205

2

A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.

Liu HB, Xu B, Qiao SB, Yang YJ, Ma WH, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Li JJ, Chen JL, Gao RL. Liu HB, et al. Chin Med J (Engl). 2007 Apr 5;120(7):574-7. Chin Med J (Engl). 2007. PMID: 17442205

3

Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.

Grube E, Buellesfeld L. Grube E, et al. Herz. 2004 Mar;29(2):162-6. doi: 10.1007/s00059-004-2556-6. Herz. 2004. PMID: 15054588 Review.

4

Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.

Liu HB, Xu B, Yang YJ, Wang Y, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Ma WH, Li JJ, Qiao SB, Chen JL, Li W, Gao RL. Liu HB, et al. Chin Med J (Engl). 2009 Mar 20;122(6):681-6. Chin Med J (Engl). 2009. PMID: 19323934

5

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW. García-García HM, et al. Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Arch Cardiol Mex. 2006. PMID: 17091802 Review.

6

[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].

Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Schöbel WA, Sabin G, Senges J; deutsche Cyper-Register. Zahn R, et al. Herz. 2004 Mar;29(2):181-6. doi: 10.1007/s00059-004-2560-x. Herz. 2004. PMID: 15057439 German.

7

Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.

Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR. Fan L, et al. Chin Med J (Engl). 2008 Aug 20;121(16):1518-23. Chin Med J (Engl). 2008. PMID: 18982862

8

Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.

Bhargava B, Karthikeyan G, Shankar PB, Seth S, Singh S, Pr U, Lal AV, Mohanty M. Bhargava B, et al. Indian Heart J. 2008 May-Jun;60(3):228-32. Indian Heart J. 2008. PMID: 19240312

9

ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?

Buellesfeld L, Grube E. Buellesfeld L, et al. Herz. 2004 Mar;29(2):167-70. doi: 10.1007/s00059-004-2557-5. Herz. 2004. PMID: 15054589 Review.

10

Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement.

Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, Mügge A, Di Pede F, Füllgraf D, Aengevaeren W, Spedicato L, Popma JJ. Neumann FJ, et al. Circulation. 2005 Apr 26;111(16):2107-11. doi: 10.1161/01.CIR.0000162467.53001.6B. Circulation. 2005. PMID: 15851617 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

483 results

Results by year